In this episode of "The Top Line," we talk with Vimala Raghavendran, the vice president of informatics and product development at U.S. Pharmacopeia, about the factors causing the ongoing chemotherapy shortage. We also cover the Grail harassment lawsuits, CRISPR for Alzheimer's drug development, and the rest of the week's headlines.
To learn more about the topics in this episode:
"The Top Line" is produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.
See omnystudio.com/listener for privacy information.
Create your
podcast in
minutes
It is Free